Agios Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
AGIO chart
What traders are saying about $AGIO
Latest postsAgios Pharmaceuticals, Inc. news
- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Simply Wall St ·
- Agios Pharmaceuticals (AGIO) Stock Looks Pricey Despite Its 39% Run
Yahoo Finance ·
- Agios Pharmaceuticals Inc (AGIO) (Q3 2026) Earnings Call Highlig
GuruFocus ·
- Agios Pharmaceuticals Inc (AGIO) (Q3 2026) Earnings Call Highlights: Revenue Surges 4x on ...
Yahoo Finance ·
- Truist Securities maintains Agios Pharmaceuticals at Buy, lowers price target to $35 from $37
TradingView ·
- RBC Capital Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Maintains Target Price $32
Moomoo ·
- Agios axes 100-plus R&D roles while awaiting FDA decision
BioSpace ·
- HC Wainwright & Co. maintains Agios Pharmaceuticals at Buy, raises price target to $62 from $55
TradingView ·
- Is Agios Pharmaceuticals (AGIO) A Bargain Following Record Revenue And An FDA Review Delay?
Simply Wall St ·
- Agios Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Agios Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Agios Pharmaceuticals cutting over 100 R&D jobs as it shifts focus to commercial launches
The Business Journals ·
Agios Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $54.0M | $36.5M | $26.8M | $14.2M |
| Net income | -$413.0M | $674.0M | -$352.0M | -$232.0M |
| Diluted EPS | $-7.12 | $11.64 | $-6.33 | $-4.23 |
| Total assets (year end) | $1.30B | $1.66B | $937.1M | $1.24B |
| Cash and equivalents (year end) | $89.1M | $76.2M | $88.2M | $139.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Agios Pharmaceuticals, Inc.
- Ticker
- AGIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1439222
- Former names
- AGIOS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Agios Pharmaceuticals, Inc. listed on?
Agios Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AGIO.
What industry is Agios Pharmaceuticals, Inc. in?
Agios Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Agios Pharmaceuticals, Inc. headquartered?
Agios Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Agios Pharmaceuticals, Inc.'s fiscal year end?
Agios Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Agios Pharmaceuticals, Inc. report?
Agios Pharmaceuticals, Inc. reported $54.0M in revenue for calendar year 2025, according to its SEC filings.